Richard T Carback (Richard Carback)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Dendritic Cells

Room Temperature

Binding Protein

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Scott R Burkholz, Charles V Herst, Richard T Carback, Paul E Harris, Reid M Rubsamen
Survivin (BIRC5) Peptide Vaccine in the 4T1 Murine Mammary Tumor Model: A Potential Neoadjuvant T Cell Immunotherapy for Triple Negative Breast Cancer: A Preliminary Study. Vaccines 11 (3) (2023)
Sharon Wright, Scott R Burkholtz, Cathy Zelinsky, Connor Wittman, Richard T Carback, Paul E Harris, Tikoes Blankenberg, Charles V Herst, Reid M Rubsamen
Survivin Expression in Luminal Breast Cancer and Adjacent Normal Tissue for Immuno-Oncology Applications. International journal of molecular sciences 24 (14) (2023)
Scott R Burkholz, Charles V Herst, Richard T Carback, Paul E Harris, Reid M Rubsamen
Survivin (BIRC5) Peptide Vaccine in the 4T1 Murine Mammary Tumor Model: A Potential Neoadjuvant T Cell Immunotherapy for Triple Negative Breast Cancer: A Preliminary Study. Vaccines 11 (3) (2023)
Paul E Harris, Trevor Brasel, Christopher Massey, C V Herst, Scott Burkholz, Peter Lloyd, Tikoes Blankenberg, Thomas M Bey, Richard T Carback, Thomas Hodge, Serban Ciotlos, Lu Wang, Jason E Comer, Reid M Rubsamen
A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques. Vaccines 9 (5) (2021)